Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emily Y. Jen
FDA Approval: Blinatumomab for Patients With B-Cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission With Minimal Residual Disease
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients With Earlier Quantification of Minimal Residual Disease
PLoS ONE
Multidisciplinary
Transcriptome Analysis of Minimal Residual Disease in Subtypes of Pediatric B Cell Acute Lymphoblastic Leukemia
Clinical Medicine Insights: Oncology
Oncology
Detection of Minimal Residual Disease in B Cell Acute Lymphoblastic Leukemia Using an Eight-Color Tube With Dried Antibody Reagents
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
Blinatumomab in Acute Lymphoblastic Leukemia
Expert Review of Anticancer Therapy
Oncology
Pharmacology
Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States
PharmacoEconomics
Health Policy
Public Health
Occupational Health
Pharmacology
Environmental
Pcn77 - Budget Impact Analysis of Blinatumomab for the Treatment of Pediatric Patients With Philadelphia Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Mexico
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Minimal Residual Disease in Childhood B Lymphoblastic Leukemia and Its Correlation With Other Risk Factors
Pakistan Journal of Medical Sciences
Medicine
Clinical Significance of Minimal Residual Disease at the End of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
Open Access Macedonian Journal of Medical Sciences
Medicine
Neonatal Inflammatory Markers Are Associated With Childhood B-Cell Precursor Acute Lymphoblastic Leukemia
Cancer Research
Cancer Research
Oncology
